243 related articles for article (PubMed ID: 33021485)
1. Evaluation of a Heart Failure Telemonitoring Program Through a Microsimulation Model: Cost-Utility Analysis.
Boodoo C; Zhang Q; Ross HJ; Alba AC; Laporte A; Seto E
J Med Internet Res; 2020 Oct; 22(10):e18917. PubMed ID: 33021485
[TBL] [Abstract][Full Text] [Related]
2. A Mobile Phone-Based Telemonitoring Program for Heart Failure Patients After an Incidence of Acute Decompensation (Medly-AID): Protocol for a Randomized Controlled Trial.
Seto E; Ross H; Tibbles A; Wong S; Ware P; Etchells E; Kobulnik J; Chibber T; Poon S
JMIR Res Protoc; 2020 Jan; 9(1):e15753. PubMed ID: 32012116
[TBL] [Abstract][Full Text] [Related]
3. Home telemonitoring or structured telephone support programmes after recent discharge in patients with heart failure: systematic review and economic evaluation.
Pandor A; Thokala P; Gomersall T; Baalbaki H; Stevens JW; Wang J; Wong R; Brennan A; Fitzgerald P
Health Technol Assess; 2013 Aug; 17(32):1-207, v-vi. PubMed ID: 23927840
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of a Telemonitoring Program for Patients With Heart Failure During the COVID-19 Pandemic in Hong Kong: Model Development and Data Analysis.
Jiang X; Yao J; You JH
J Med Internet Res; 2021 Mar; 23(3):e26516. PubMed ID: 33656440
[TBL] [Abstract][Full Text] [Related]
5. A telemonitoring programme in patients with heart failure in France: a cost-utility analysis.
Caillon M; Sabatier R; Legallois D; Courouve L; Donio V; Boudevin F; de Chalus T; Hauchard K; Belin A; Milliez P
BMC Cardiovasc Disord; 2022 Oct; 22(1):441. PubMed ID: 36217130
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of a Heart Failure Telemonitoring Program Implemented as the Standard of Care in an Outpatient Heart Function Clinic: Pretest-Posttest Pragmatic Study.
Ware P; Ross HJ; Cafazzo JA; Boodoo C; Munnery M; Seto E
J Med Internet Res; 2020 Feb; 22(2):e16538. PubMed ID: 32027309
[TBL] [Abstract][Full Text] [Related]
7. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
[TBL] [Abstract][Full Text] [Related]
8. Telemonitoring Versus Usual Care for Elderly Patients With Heart Failure Discharged From the Hospital in the United States: Cost-Effectiveness Analysis.
Jiang X; Yao J; You JH
JMIR Mhealth Uhealth; 2020 Jul; 8(7):e17846. PubMed ID: 32407288
[TBL] [Abstract][Full Text] [Related]
9. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
[TBL] [Abstract][Full Text] [Related]
10. Vericiguat for the Treatment of Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event: A Cost-Effectiveness Analysis from the Perspective of Chinese Healthcare Providers.
Yu X; Hao Y; Zhu Z; Zhang W; Liu B; Ma M; Zhang X; Wei N; Wang J; Liu F
Clin Drug Investig; 2023 Apr; 43(4):241-250. PubMed ID: 36929485
[TBL] [Abstract][Full Text] [Related]
11. Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model.
Sutcliffe P; Connock M; Pulikottil-Jacob R; Kandala NB; Suri G; Gurung T; Grove A; Shyangdan D; Briscoe S; Maheswaran H; Clarke A
Health Technol Assess; 2013 Nov; 17(53):1-499, v-vi. PubMed ID: 24280231
[TBL] [Abstract][Full Text] [Related]
12. Cost-Effectiveness of Transitional Care Services After Hospitalization With Heart Failure.
Blum MR; Øien H; Carmichael HL; Heidenreich P; Owens DK; Goldhaber-Fiebert JD
Ann Intern Med; 2020 Feb; 172(4):248-257. PubMed ID: 31986526
[TBL] [Abstract][Full Text] [Related]
13. Long-term cost-effectiveness of home versus clinic-based management of chronic heart failure: the WHICH? study.
Maru S; Byrnes JM; Carrington MJ; Stewart S; Scuffham PA
J Med Econ; 2017 Apr; 20(4):318-327. PubMed ID: 27841726
[TBL] [Abstract][Full Text] [Related]
14. The cost effectiveness of REACH-HF and home-based cardiac rehabilitation compared with the usual medical care for heart failure with reduced ejection fraction: A decision model-based analysis.
Taylor RS; Sadler S; Dalal HM; Warren FC; Jolly K; Davis RC; Doherty P; Miles J; Greaves C; Wingham J; Hillsdon M; Abraham C; Frost J; Singh S; Hayward C; Eyre V; Paul K; Lang CC; Smith K
Eur J Prev Cardiol; 2019 Aug; 26(12):1252-1261. PubMed ID: 30884975
[TBL] [Abstract][Full Text] [Related]
15. A Canadian cost-effectiveness analysis of transcatheter mitral valve repair with the MitraClip system in high surgical risk patients with significant mitral regurgitation.
Cameron HL; Bernard LM; Garmo VS; Hernandez JB; Asgar AW
J Med Econ; 2014 Aug; 17(8):599-615. PubMed ID: 24826880
[TBL] [Abstract][Full Text] [Related]
16. Cost-Effectiveness Analysis in Telehealth: A Comparison between Home Telemonitoring, Nurse Telephone Support, and Usual Care in Chronic Heart Failure Management.
Grustam AS; Severens JL; De Massari D; Buyukkaramikli N; Koymans R; Vrijhoef HJM
Value Health; 2018 Jul; 21(7):772-782. PubMed ID: 30005749
[TBL] [Abstract][Full Text] [Related]
17. The Cost-Effectiveness of Palliative Care: Insights from the PAL-HF Trial.
Kaufman BG; Granger BB; Sun JL; Sanders G; Taylor DH; Mark DB; Warraich H; Fiuzat M; Steinhauser K; Tulsky JA; Rogers JG; O'Connor C; Mentz RJ
J Card Fail; 2021 Jun; 27(6):662-669. PubMed ID: 33731305
[TBL] [Abstract][Full Text] [Related]
18. Cost-Utility of Catheter Ablation for Atrial Fibrillation in Patients with Heart Failure: An Economic Evaluation.
Lau D; Sandhu RK; Andrade JG; Ezekowitz J; So H; Klarenbach S
J Am Heart Assoc; 2021 Jul; 10(14):e019599. PubMed ID: 34238020
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of remote haemodynamic monitoring by an implantable pulmonary artery pressure monitoring sensor (CardioMEMS-HF system) in chronic heart failure in the Netherlands.
Mokri H; Clephas PRD; de Boer RA; van Baal P; Brugts JJ; Rutten-van Mölken MPMH
Eur J Heart Fail; 2024 May; 26(5):1189-1198. PubMed ID: 38560762
[TBL] [Abstract][Full Text] [Related]
20. Cost-Effectiveness of KTE-X19 for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in the United States.
Shah BD; Smith NJ; Feng C; Jeyakumar S; Castaigne JG; Faghmous I; Masouleh BK; Malone DC; Bishop MR
Adv Ther; 2022 Aug; 39(8):3678-3695. PubMed ID: 35727476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
